Ipsen et Spirogen redéfinissent leur collaboration pour le développement clinique de SJG 136 (maintenant SG2000)

This article or press release has no online content. Please download the associated documents for more information.

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2021